French act to increase breast screening
This article was originally published in Clinica
Executive Summary
Despite the introduction of a national screening programme throughout France for breast cancer, uptake has been slow. Now, the national cancer institute is organising a campaign to increase uptake; only 37% of the eligible 8 million women aged between 50 and 74 took up the offer of biennial screening in 2004. The aim of the institute is to achieve take-up rates of: 50% in 2005; 60% in 2006; and 70% thereafter.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.